Kevin Billingsley

Kevin Billingsley, MD, MBA, FACS is a Professor of Surgery (Oncology) and Chief Medical Officer at Yale Cancer Center & Smilow Cancer Hospital. He leads clinical care operations, quality initiatives, and multidisciplinary team structures across Yale New Haven Health. Specializing in hepatobiliary and pancreatic cancers, his surgical practice focuses on liver, pancreatic, and bile duct tumors with expertise in metastatic liver tumors and minimally invasive approaches. He holds an MBA from OHSU/Portland State University and completed surgical training at Johns Hopkins and Oregon Health & Science University.

Education & Training:

• MD: Johns Hopkins University School of Medicine (1989)
• MBA: Oregon Health & Science University (2020)
• Surgical Residency: Oregon Health & Science University (1992)
• Surgical Oncology Fellowship: Memorial Sloan Kettering Cancer Center (1998)

Research Interests: Develops novel treatments for metastatic colorectal liver cancer and improves outcomes for complex liver/pancreas surgeries. Focuses on clinical systems integration, patient communication strategies, and clinician resilience programs in his leadership role.

Key Contributions: Over 100 peer-reviewed publications including seminal work on perioperative FOLFIRINOX protocols, insurance disparities in cancer care, and time-to-treatment benchmarks for hepatopancreatobiliary malignancies.

Awards:

• 2017 OHSU Department of Surgery Alumni Award
• 2014 AHPBA Travelling Fellow Award
• 2008 OHSU Teaching Award
• 2007 James IV Travelling Fellowship